Comparison

BPTU

Item no. CS-8114-50mg
Manufacturer ChemScene
Amount 50mg
Category
Type Molecules
Specific against other
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Similar products 870544-59-5
Available
Alternative Names
BMS-646786
CAS
870544-59-5
Purity
>98%
Formula
C23H22F3N3O3
MWt
445.43
Solubility
DMSO : >= 33.3 mg/mL (74.76 mM); H2O : < 0.1 mg/mL (insoluble)
Clinical Information
No Development Reported
Pathway
GPCR/G Protein
Target
P2Y Receptor
Biological Activity
BPTU is a novel P2Y1 allosteric antagonist. IC50 & Target: P2Y1[1] In Vitro: BPTU blocks the supramaximal fast inhibitory junction potentials (fIJP) in a concentration-dependent manner both in the rat and mouse colon (P<0.0001 for both). The EC50 of BPTU is approximately 0.3 uM and 0.06 uM for the rat and mouse colon, respectively. In the rat colon, addition of the P2Y agonist ADPbetaS at 10 uM significantly reduces spontaneous contractions to a 43.2+/-13.4% (N=5) (P=0.0002), and this reduction is blocked by 15 min incubation with BPTU at a concentration of 3 uM (93.3+/-5.1%). Similar results are obtained in the murine colon where ADPbetaS at 10 uM reduces the area under the curve (AUC) of contractions to a 15.8+/-5.1% (N=4) (P<0.0001) and its effect is reversed with BPTU at 3 uM (82.7+/-3.6%). Addition of MRS2365, a selective P2Y1 agonist, at a concentration of 5 uM significantly reduces spontaneous contractions to a 21.2+/-4.8% (N=5) (P=0.0002) in the murine colon, and this reduction is blocked by 15 min incubation with BPTU at a concentration of 3 uM (93.1+/-3.8%). The blockage of the MRS2365-induced response by BPTU at 3 uM also occurs in control conditions (N=5) (10.2+/-5.5% vs. 86.7+/-5.0%)[1]. In Vivo: Uptake of BPTU from the peritoneal cavity is relatively rapid. Blood boron levels are maximal within 1 h after administration. After only 1 h, a boron tumor-to-blood ratio above 1 is found for BPTU in pigmented tumors, which is indicative of drug retention. This is not seen in the non-pigmented tumor variant, in which tumor boron levels closely follow blood levels. Up to 24 h, Borocaptate sodium (BSH) exhibits no selective retention in either tumor, but achieves higher maximum tumor boron concentrations than BPTU as a result of the administration of higher amounts of boron. During the tissue distribution phase, liver-to-kidney boron concentration ratios range from 2 to 4 for BSH and from 0.5 to 1 for BPTU[2].

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close